An effective vaccine is only the first step: the need to create and sustain demand for TB vaccines.

Nelson, K N; Shah, N S; Cranmer, L M; Vasudevan, L; Bednarczyk, R A

Nelson, K N; Shah, N S; Cranmer, L M; Vasudevan, L; Bednarczyk, R A.

Afiliação

Nelson KN; Department of Epidemiology, Emory University Rollins School of Public Health.
Shah NS; Department of Epidemiology, Emory University Rollins School of Public Health, Department of Global Health, Emory University Rollins School of Public Health, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Cranmer LM; Department of Epidemiology, Emory University Rollins School of Public Health, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Vasudevan L; Department of Global Health, Emory University Rollins School of Public Health.
Bednarczyk RA; Department of Epidemiology, Emory University Rollins School of Public Health, Department of Global Health, Emory University Rollins School of Public Health.

Int J Tuberc Lung Dis ; 27(10): 718-720, 2023 10 01.

Article em En | MEDLINE | ID: mdl-37749838

Assuntos

Vacinas contra a Tuberculose; Tuberculose; Humanos; Tuberculose/prevenção & controle

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Tuberculose / Vacinas contra a Tuberculose Limite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google